Celebrating 17 Years of Advancing Biopharma R&D Innovation, Decision Making and Operations
A conference for people at the intersection of science, business & operations…
In an environment of declining revenues and uncertain commercial
success, biopharma, device, and R&D companies must continuously optimize
their strategy, evaluate their portfolios, improve decision making, reduce
risk, and effectively deploy resources. The oncology and immuno-oncology fields
face these challenges and more given the shifting paradigms in this disease
area. Cambridge Healthtech Institute and the BioPharma Strategy Series present a full week of high-level content, interactive discussions and networking at the 2nd Annual “Strategic and Operational Challenges of Immuno-Oncology
Drug Development” (Mon-Tues), a “Decision Analysis & Project Portfolio Management Master Class” (Mon-Tues), 17th Annual “Strategic Resource Management” (Wed-Thurs), and 14th Annual “Portfolio Management”
(Thurs-Fri).
Cambridge Healthtech Institute’s annual executive forum brings together R&D executives from the biopharma community to share best practices in project and portfolio management, R&D innovation, decision analysis, forecasting, resource
management, and immuno-oncology drug development. Attendees will gain strategic insights and proven tools, methods, and perspectives from a variety of leaders at the intersection of science, business, and operations.